.
Novo Nordisk's share price may grow again as a result of this significant development.
It may not be too late to invest in this promising healthcare stock, even though it may look expensive.
Tag: Weight loss
This one figure could ensure Eli Lilly's dominance of the weight-loss drug market.
Lilly's stock price has climbed triple digits in the past 12 months.
Is it too late to buy shares of Viking Therapeutics?
Viking Therapeutics' stock has soared following the success of its Phase II trial of its obesity drug candidate.
English 
Chinese